会议摘要:2021年全球疫苗与免疫研究论坛
2021年全球疫苗与免疫研究论坛回顾了COVID-19疫苗研发中基础研究投资、新技术平台和原型病原体疫苗带来的快速全球响应,以及全球协调合作的作用;同时指出需改进产品可交付性和疫苗公平可及性,并汇总了HIV、结核、疟疾、HPV和脊髓灰质炎疫苗的进展,强调消除地方性流行病与应急准备相互交织。
要点
- COVID-19疫苗快速全球响应得益于数十年基础与转化研究投资、新技术平台和针对原型病原体的疫苗。
- 产品属性如可交付性以及疫苗公平可及性仍需改进。
- HIV疫苗试验因预防感染缺乏效力而终止;两种结核疫苗2期试验显示有前景的效力结果。
核心结论
- COVID-19大流行期间取得的进展应加速其他疾病疫苗的可及性,促进对未来大流行的准备,并有助于在免疫议程2030下实现影响和公平。
研究设计与样本
- 2021年全球疫苗与免疫研究论坛会议摘要,综述了疫苗与免疫研发进展、COVID-19疫苗项目经验教训以及未来十年机遇。
主要发现
- COVID-19疫苗快速全球响应得益于数十年基础与转化研究投资、新技术平台和针对原型病原体的疫苗。
- HIV疫苗试验因预防感染缺乏效力而终止;两种结核疫苗2期试验显示有前景的效力结果。
- 最先进疟疾候选疫苗在三国家试点实施;HPV疫苗单剂方案试验;新型口服2型脊髓灰质炎疫苗获紧急使用列表。
- 产品属性如可交付性以及疫苗公平可及性仍需改进。
临床怎么用
- 与会者强调解决地方性流行病与应急准备和大流行响应相互交织,一个领域的进展为另一个领域创造机会。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The 2021 Global Vaccine and Immunization Research Forum highlighted the considerable advances and recent progress in research and development for vaccines and immunization, critically reviewed lessons learned from COVID-19 vaccine programs, and looked ahead to opportunities for this decade. For COVID-19, decades of investments in basic and translational research, new technology platforms, and vaccines targeting prototype pathogens enabled a rapid, global response. Unprecedented global coordination and partnership have played an essential role in creating and delivering COVID-19 vaccines. More improvement is needed in product attributes such as deliverability, and in equitable access to vaccines. Developments in other priority areas included: the halting of two human immunodeficiency virus vaccine trials due to lack of efficacy in preventing infection; promising efficacy results in Phase 2 trials of two tuberculosis vaccines; pilot implementation of the most advanced malaria vaccine candidate in three countries; trials of human papillomavirus vaccines given in single-dose regimens; and emergency use listing of a novel, oral poliomyelitis type 2 vaccine. More systematic, proactive approaches are being developed for fostering vaccine uptake and demand, aligning on priorities for investment by the public and private sectors, and accelerating policy making. Participants emphasized that addressing endemic disease is intertwined with emergency preparedness and pandemic response, so that advances in one area create opportunities in the other. In this decade, advances made in response to the COVID-19 pandemic should accelerate availability of vaccines for other diseases, contribute to preparedness for future pandemics, and help to achieve impact and equity under Immunization Agenda 2030.
引用
- Ford A, Hwang A, Mo AX, et al. Meeting Summary: Global Vaccine and Immunization Research Forum, 2021. Vaccine. 2023. PMID: 36803897. doi:10.1016/j.vaccine.2023.02.028
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。